QIAGEN N.V. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
QIAGEN N.V. (QGEN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of -3.60% for the 12-month period ending 2014-12-31, per its 20-F filed 2015-03-02.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2015-03-02
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month |
|---|---|
| 2014-12-31 | -3.60% 20-F · filed 2015-03-02 |
| 2013-12-31 | -5.90% 20-F · filed 2015-03-02 |
| 2012-12-31 | -0.80% 20-F · filed 2015-03-02 |
| 2011-12-31 | -0.70% 20-F · filed 2014-03-03 |